MarketPeel
Insider Trading Intelligence
RL

Rivervest Venture Fund Iv, L.p.

XLO
10% OWNER · XILIO THERAPEUTICS, INC. · CIK 0001725443
FILING MIX · LIFETIME60%/40%
BUYS
6
SELLS
4
TOTAL VALUE
$7.75M
COMPANIES
2
ACTIVE SINCE
Oct 2020
HOLDINGS NOW
1,070,172
AVG SELL PX
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Rivervest Venture Fund Iv, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%+17.75%-0.10%+17.84%+17.84%
14d2+100.00%+32.54%-1.80%+34.34%+34.34%
30d2+100.00%+26.06%+2.94%+23.11%+23.11%
60d2+50.00%+11.35%+4.19%+7.16%+7.16%
90d2+50.00%+4.69%+3.07%+1.63%+1.63%
180d2+0.00%-42.63%+6.90%-49.53%-49.53%
1y2+0.00%-79.94%+7.01%-86.96%-86.96%
2y2+0.00%-90.48%-0.44%-90.04%-90.04%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
XLO · 0 shares · as of Oct 26, 2021
0360,361720,7221,081,0831,441,444SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
2021
2021
FLOW · 6 buys / 4 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
359,3241,191,444Oct 26, 2021Oct 26, 2021
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
832,120832,120Oct 26, 2021Oct 26, 2021
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
250,000$16.00$4.00M1,441,444Oct 26, 2021Oct 26, 2021
XLO
XILIO THERAPEUTICS, INC.
SALE
359,3240Oct 26, 2021Oct 26, 2021
XLO
XILIO THERAPEUTICS, INC.
SALE
832,1200Oct 26, 2021Oct 26, 2021
SPRB
SPRUCE BIOSCIENCES, INC.
PURCHASE
828,1091,898,281Oct 14, 2020Oct 16, 2020
SPRB
SPRUCE BIOSCIENCES, INC.
SALE
7,000,0000Oct 14, 2020Oct 16, 2020
SPRB
SPRUCE BIOSCIENCES, INC.
PURCHASE
250,000$15.00$3.75M2,148,281Oct 14, 2020Oct 16, 2020
SPRB
SPRUCE BIOSCIENCES, INC.
SALE
5,416,6660Oct 14, 2020Oct 16, 2020
SPRB
SPRUCE BIOSCIENCES, INC.
PURCHASE
1,070,1721,070,172Oct 14, 2020Oct 16, 2020
Other insiders · XLO
Loading peer insiders…
About this filer
CIK 0001725443
ROLE
10% Owner
PRIMARY
XLO
COMPANIES
2
ACTIVE SINCE
Oct 2020
MARKETPEEL · /INSIDER/0001725443DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback